Gene · 5817
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical and translational progress in oncolytic virotherapy for pediatric CNS tumors. | J Neurooncol | 2026 | 41741902 | PubTator, text mining | PubMed |
| Integrated network analysis and experimental validation identify CCNA2, CD44, and STAT1 as clinically relevant hub genes in oral squamous cell carcinoma. | Front Mol Biosci | 2026 | 41737827 | PubTator, text mining | PubMed |
| Natural killer cell-inspired dendritic mesoporous rare-earth nanoparticles potentiate X-ray-triggered reactive oxygen generation for low-dose radiotherapy-radiodynamic therapy. | Bioact Mater | 2026 | 41737643 | PubTator, text mining | PubMed |
| Editorial: Regulators of the immune-tumor microenvironment: a new frontier for cancer immunotherapy. | Front Med (Lausanne) | 2026 | 41737407 | PubTator, text mining | PubMed |
| Specific depletion of TIGIThigh CD226- clonally expanded intratumoral Tregs defines safe and effective TIGIT targeting. | J Immunother Cancer | 2026 | 41735000 | PubTator, text mining | PubMed |
| Effective allogeneic natural killer cell therapy for pancreatic adenocarcinoma avails conserved activating receptors and evades HLA I-driven inhibition. | J Immunother Cancer | 2026 | 41734996 | PubTator, text mining | PubMed |
| Comprehensive analysis of mitochondrial unfolded protein response related genes for prognosis and therapeutic response in pancreatic cancer. | Front Immunol | 2026 | 41727504 | PubTator, text mining | PubMed |
| High PVR protein expression marks clear cell renal cell carcinoma with metastatic spread. | Front Immunol | 2026 | 41727425 | PubTator, text mining | PubMed |
| Comprehensive efficacy of different prostate resection volumes for patients with benign prostatic hyperplasia: a systematic review and meta-analysis. | PeerJ | 2026 | 41727237 | PubTator, text mining | PubMed |
| Association of parental verbal responsivity with reduced mental health problems in preschool-aged children: a cross-sectional study of 21,366 dyads in western China. | Front Psychol | 2026 | 41725672 | PubTator, text mining | PubMed |
| Identification of circulatory neuro-related proteins in Parkinson's disease: an integrated genetic-proteomic-clinical study. | EBioMedicine | 2026 | 41724112 | PubTator, text mining | PubMed |
| Single-cell epigenetic profiling reveals a tumor-intrinsic interferon response program in ccRCC tied to poor prognosis and BAP1 loss. | Sci Adv | 2026 | 41719400 | PubTator, text mining | PubMed |
| Protocol for evaluating the economic viability of adiabatic compressed air energy storage systems. | STAR Protoc | 2026 | 41719135 | PubTator, text mining | PubMed |
| Deep immune-phenotyping of HLA-homozygous iPS-cardiomyocytes by spectral flow cytometry. | Front Immunol | 2026 | 41716415 | PubTator, text mining | PubMed |
| Polymorphonuclear myeloid-derived suppressor cells inhibit natural killer cell function in neuromyelitis optica spectrum disorder via the CD155-TIGIT axis. | Clin Immunol | 2026 | 41713715 | PubTator, text mining | PubMed |
| Luteolin mitigates proliferative vitreoretinopathy through inhibition of ERK1/2 signaling and epithelial-mesenchymal transition. | Front Pharmacol | 2026 | 41710935 | PubTator, text mining | PubMed |
| Single-cell multiomic atlas of healthy pediatric bone marrow reveals age-dependent differences in lineage differentiation driven by stromal signaling. | Nat Immunol | 2026 | 41703319 | PubTator, text mining | PubMed |
| The immunopathological crosstalk of diabetic periodontitis: Single-cell insights into monocyte dysregulation. | PLoS One | 2026 | 41701724 | PubTator, text mining | PubMed |
| A CD57+CD8+ T cell subset links T cell cytotoxicity to fibrotic lung disease in systemic sclerosis. | J Clin Invest | 2026 | 41701649 | PubTator, text mining | PubMed |
| Real world outcomes of intravitreal and systemic therapy in primary and secondary vitreoretinal lymphoma. | Sci Rep | 2026 | 41690970 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5817/papers?page=7